Closed · RFA-PS-23-004 · CFDA 93.084 · Discretionary
Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $750K-$1M
- Award range
- Closed
- Status
- February 27, 2023
- Close date
- 1
- Expected awards
The verdict
Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $750,000 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number.
- $750K-$1M
- award range
- Closed
- application status
- 1
- expected award
- 93.084
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings - is cataloged under number RFA-PS-23-004 and tied to CFDA assistance listing 93.084, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on December 22, 2022 and last updated on February 2, 2023. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is $750,000 -- $1,000,000. The agency has projected $4.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $4.0 million estimated pool, the average award works out to roughly $4.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on February 27, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$750,000 -- $1,000,000
Close Date
February 27, 2023
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
December 22, 2022
Est. Total Funding
$4,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
The purpose of this notice of funding opportunity is to support research on Long-Acting Injectable-Antiretroviral Therapy (LAI-ART) by implementing LAI-ART administration in both clinic and non-clinic settings (e.g., community pharmacies). A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART. Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability. Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression. The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Jocelyn Patterson Mosley fzp0@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
RFA-IP-18-000
RFA-CC-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |